• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Catherine Hollingsworth

Catherine Hollingsworth

Articles

ARTICLES

Elan Cutting Biotech, Eliminating 230 Jobs

March 4, 2009
By Catherine Hollingsworth

FDA Wants Risk Plan for Telavancin Use in cSSSI

March 2, 2009
By Catherine Hollingsworth

Clinical Data Completes $50M Debt Deal for Phase III Drugs

Feb. 27, 2009
By Catherine Hollingsworth

Elan Cutting Biotech, Eliminating 230 Jobs

Feb. 26, 2009
By Catherine Hollingsworth

MAP Phase III Asthma Study Fails to Hit Mark in Pediatric Patients

Feb. 25, 2009
By Catherine Hollingsworth
MAP Pharmaceuticals Inc. said that its potential treatment for asthma in children did not improve symptoms any better than placebo in a Phase III study of unit dose budesonide (UDB), leaving the program in limbo for now and causing its shares to fall more than 75 percent. (BioWorld Today)
Read More

Sucampo Gets $10M Up Front in Abbott Japan Drug Deal

Feb. 23, 2009
By Catherine Hollingsworth

Debt Woes Loom Large For Struggling Drugmakers

Feb. 23, 2009
By Catherine Hollingsworth
Recent headlines show the bad news has been mounting for months as biotech firms, struggling to raise cash, announced layoffs, corporate restructurings and bankruptcy filings.
Read More

Vertex Aims for $320M Offering to Push Telaprevir to the Finish

Feb. 20, 2009
By Catherine Hollingsworth
Vertex Pharmaceuticals Inc. is likely to have a big enough pot of cash to launch telaprevir for hepatitis C virus and to advance a potential treatment for cystic fibrosis, now that it has agreed to sell 10 million new shares. (BioWorld Today)
Read More

Novelos, Mundipharma Sign $95M Deal for Cancer Drug

Feb. 18, 2009
By Catherine Hollingsworth
Novelos Therapeutics Inc. has signed a $95 million deal with Mundipharma International Corp. Ltd. to market a cancer drug in Europe and Japan, with $10 million of that paid up front by Purdue Pharma LP, an independent company associated with the UK firm. (BioWorld International)
Read More

Cadence Seeking $86.6M for 2 Phase III Candidates

Feb. 18, 2009
By Catherine Hollingsworth
View All Articles by Catherine Hollingsworth

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for August 8, 2025.
  • Heart, artery with cholesterol, brain

    In Broadway trial, a hopeful tune for Alzheimer’s prevention

    BioWorld
    At the 2025 Alzheimer’s Association International Conference (AAIC), one of the bigger splashes was made by a cardiovascular drug. In a presentation on July 30,...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for August 5, 2025
  • NME Digest: Q2 2025

    BioWorld Science
    A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe